Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX
· Real-Time Price · USD
4.34
-0.09 (-2.03%)
At close: May 13, 2025, 9:46 AM
Foghorn Therapeutics Revenue
Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending December 31, 2024, Foghorn Therapeutics generated $2.86M in revenue.
Revenue (ttm)
$22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
$201.8K
Employees
112
Market Cap
241.83M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|